Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-01-30Clinical Trial Update: Varenicline in Bipolar Depressed Patients [NA]
Results from a completed clinical trial evaluating varenicline in bipolar depressed patients have been posted.
-
FDA approval · 2012-01-27FDA Approved: EQUETRO — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for EQUETRO (carbamazepine) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2012-01-27FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Lithium Carbonate from Hikma Pharmaceuticals USA Inc., resulting in an approved change to the ex…
-
FDA approval · 2012-01-26FDA Approved: CARBAMAZEPINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for the generic anticonvulsant carbamazepine from Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2012-01-25Clinical Trial Update: Omega 3 Fatty Acid Trial [Phase 1]
A Phase 1 clinical trial of omega-3 fatty acids for pediatric bipolar disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-01-24FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2012-01-24FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS withdrawal · 2012-01-11Clinical Trial Update: Pilot Study of the Effects of Circadian Rhythms on the Treatment of Bipolar I Depression. [NA]
A pilot clinical trial investigating the effects of circadian rhythms on treatment of Bipolar I Depression was withdrawn from the registry.
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition [Phase 1]
This clinical trial update reports the completion of a Phase 1 bioequivalence study of olanzapine orally disintegrating tablets (5 mg) under…
-
FDA approval · 2012-01-03FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for risperidone from Torrent Pharmaceuticals Limited.
-
FDA approval · 2012-01-03FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for risperidone from Zydus Lifesciences Limited, enabling changes to an already approved generic…
-
CLINICAL_TRIALS research · 2011-12-29Clinical Trial Update: Evaluation of Generalization Paradigm Patterns Among Different Psychiatric Disorders
A clinical trial update evaluating generalization paradigm patterns across multiple psychiatric disorders, including major depressive disord…
-
CLINICAL_TRIALS trial_result · 2011-12-21Clinical Trial Update: Customized Medication Adherence Enhancement for Treating Adults With Bipolar Disorder [NA]
This clinical trial update reports the results of a study evaluating a customized medication adherence enhancement intervention for adults w…
-
CLINICAL_TRIALS trial_result · 2011-12-20Clinical Trial Update: A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.
A completed clinical trial evaluating the efficacy of administered maintenance treatments in Bipolar Disorder.
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder [Phase 3]
A Phase 3 trial evaluating risperidone as monotherapy in adults with bipolar disorder and concurrent anxiety disorders has completed.
-
FDA approval · 2011-12-06FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lithium carbonate from Hikma Pharmaceuticals USA Inc. The approval updates the product under…
-
CLINICAL_TRIALS trial_result · 2011-12-01Clinical Trial Update: Pediatric Bipolar Depression [Phase 3]
A sponsor-led Phase 3 trial evaluating treatment for pediatric bipolar depression has completed with results posted in 2011.
-
FDA label_change · 2011-11-29FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal ODT (lamotrigine) filed by GlaxoSmithKline, resulting in changes to the product labelin…
-
FDA approval · 2011-11-29FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL XR (lamotrigine) from GlaxoSmithKline, indicating an updated approval related to the ex…
-
FDA label_change · 2011-11-29FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal (lamotrigine) to update the product labeling.
-
FDA approval · 2011-11-29FDA Approved: RISPERIDONE — Original Application (Solco Healthcare US, LLC)
The FDA approved the original application for a generic risperidone manufactured by Solco Healthcare US, LLC. The approval covers standard i…
-
FDA approval · 2011-11-28FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for a generic risperidone product from Amneal Pharmaceuticals NY LLC under ANDA 078071.
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Customized Medication Adherence Enhancement for Adults With Bipolar Disorder [NA]
A completed clinical trial evaluating a customized medication adherence enhancement intervention for adults with bipolar disorder has posted…
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness [Phase 3]
Phase 3 trial assessing the impact of genetic counseling for female first-degree relatives of individuals with schizophrenia, bipolar disord…
-
CLINICAL_TRIALS withdrawal · 2011-11-23Clinical Trial Update: Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder [Phase 2]
A Phase 2 clinical trial investigating mitochondrial dysfunction in bipolar disorder has been withdrawn.